Maintain strict timing for administration to your research models to minimize variability in your data
J.ZhangJ.YangW.WuM
Typical steps include: consultation with a qualified provider health history review lab testing personalized treatment planning progress monitoring adjustments when needed A guided process helps ensure your care remains personalized and responsive to your progress
Nevertheless, some human MTCs may express GLP-1 receptors so it is recommended to avoid these agents in people with a family or personal history of MTC or multiple endocrine neoplasia type 2
Persistent nausea or vomiting that is not improving after the first few weeks, or that is significantly affecting their ability to eat or function Mood changes that are lasting beyond the initial adjustment period, or that are notably affecting their daily life or your relationship Significant fatigue that is not improving as treatment progresses Signs of nutritional difficulty, such as extreme weakness, hair loss, or other symptoms that suggest they are not meeting nutritional needs Any change in how the medication is making them feel that they seem reluctant to raise because they do not want to seem like they are complaining or asking for the treatment to stop Your role here is not to diagnose or to manage their treatment
Incomplete submissions trigger requests for additional information, which extend the timeline by days or weeks
